Author

Natasha Pillay‐Smiley

Cincinnati Children's Hospital Medical CenterORCID 0009-0007-4203-4056Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Charles B. StevensoniD· 2 shared Peter M K de BlankiD· 2 shared Trent Ryan HummeliD· 2 shared Abby GrieriD· 1 shared Ali TavassoliiD· 1 shared Angelo D’AlessandroiD· 1 shared Arman Esshaghi BayatiD· 1 shared Biplab DasguptaiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Charles B. StevensonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 29, 2025

A Tonic Signaling Code Predicts CAR-T Cell Efficacy in Diffuse Midline Glioma

Emily Deng, Xiaowen Zhong, Dazhuan Eric Xin…·Q. Richard Lu

This study identifies tonic signaling as a key factor in CAR-T cell efficacy for diffuse midline glioma, showing that restrained tonic signaling improves therapeutic outcomes.

DOI 10.1101/2025.09.29.679095

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 21, 2025

Integrative Multi-Omics Analysis Identifies Nuclear Factor I as a Key Driver of Dysregulated Purine Metabolism in DIPG

Ian Mersich, Sunny Congrove, Matthew J. Horchar…·Biplab Dasgupta

This study identifies nuclear factor I (NFI) as a driver of dysregulated purine metabolism in DIPG, showing that targeting ATIC reduces tumor progression in mice.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky